Institutional Ownership Nurix Therapeutics, Inc. (NRIX)
This table provides information about the institutional ownership of Nurix Therapeutics, Inc. (NRIX). We have compiled data on the 182 institutions that hold shares in the stock, with a total of 74.4 Million shares, which have been reported (via 13F filing form) to have a value of $899 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
700,317
shares
|
$8.47 Million
0.0% of portfolio
|
Q1 2025
Added 6.14%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
673,147
shares
|
$8.14 Million
0.0% of portfolio
|
Q1 2025
Added 796.18%
|
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
May 14, 2025 Q1 2025 |
638,609
shares
|
$7.72 Million
0.01% of portfolio
|
Q1 2025
New holding
|
|
|
Candriam S.C.A.
|
May 14, 2025 Q1 2025 |
588,931
shares
|
$7.12 Million
0.04% of portfolio
|
Q1 2025
Reduced 7.2%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
582,066
shares
|
$7.04 Million
0.0% of portfolio
|
Q1 2025
Added 1.61%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
575,312
shares
|
$6.96 Million
0.0% of portfolio
|
Q1 2025
Added 13.51%
|
|
|
Wasatch Advisors Inc
Salt Lake City, UT |
May 15, 2025 Q1 2025 |
569,797
shares
|
$6.89 Million
0.04% of portfolio
|
Q1 2025
Reduced 4.94%
|
|
|
Samlyn Capital, LLC
New York, NY |
May 15, 2025 Q1 2025 |
515,103
shares
|
$6.23 Million
0.1% of portfolio
|
Q1 2025
Reduced 0.14%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
507,471
shares
|
$6.14 Million
0.0% of portfolio
|
Q1 2025
Added 9.49%
|
|
|
Patient Square Capital LP
Menlo Park, CA |
May 14, 2025 Q1 2025 |
447,296
shares
|
$5.41 Million
2.2% of portfolio
|
Q1 2025
Added 0.22%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
415,186
shares
|
$5.02 Million
0.0% of portfolio
|
Q1 2025
Added 175.08%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
409,637
shares
|
$4.95 Million
0.0% of portfolio
|
Q4 2024
Reduced 39.18%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 09, 2025 Q1 2025 |
380,148
shares
|
$4.6 Million
0.0% of portfolio
|
Q4 2024
Added 39.73%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
May 15, 2025 Q1 2025 |
350,420
shares
|
$4.24 Million
0.54% of portfolio
|
Q1 2025
Reduced 34.15%
|
|
|
Ponoi Ii Management, LLC
San Francisco, CA |
Nov 14, 2022 Q3 2022 |
327,123
shares
|
$3.95 Million
11.14% of portfolio
|
Q4 2021
Reduced 41.75%
|
|
|
Ponoi Management, LLC
San Francisco, CA |
Nov 14, 2022 Q3 2022 |
327,123
shares
|
$3.95 Million
5.82% of portfolio
|
Q2 2022
Added 0.0%
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
May 15, 2025 Q1 2025 |
314,762
shares
|
$3.81 Million
0.07% of portfolio
|
Q4 2023
New holding
|
|
|
Bessemer Group Inc
Woodbridge, NJ |
Apr 23, 2025 Q1 2025 |
306,003
shares
|
$3.7 Million
0.01% of portfolio
|
Q4 2024
Reduced 0.02%
|
|
|
Perceptive Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
297,553
shares
|
$3.6 Million
0.15% of portfolio
|
Q1 2025
Reduced 10.0%
|
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
294,747
shares
|
$3.56 Million
0.0% of portfolio
|
Q1 2025
Reduced 16.61%
|
|
|
Integral Health Asset Management, LLC
|
May 15, 2025 Q1 2025 |
275,000
shares
|
$3.32 Million
0.38% of portfolio
|
Q1 2025
Added 10.0%
|
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
257,525
shares
|
$3.11 Million
0.01% of portfolio
|
Q1 2025
Added 90.64%
|
|
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
May 14, 2025 Q1 2025 |
249,336
shares
|
$3.01 Million
0.35% of portfolio
|
Q1 2025
Reduced 14.02%
|
|
|
Primecap Management CO
Pasadena, CA |
May 09, 2025 Q1 2025 |
232,000
shares
|
$2.8 Million
0.0% of portfolio
|
Q4 2024
Reduced 20.0%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
May 14, 2025 Q1 2025 |
230,828
shares
|
$2.79 Million
0.01% of portfolio
|
Q1 2025
Reduced 38.39%
|